We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck KGaA, Darmstadt, Germanys current and future businesses.We are the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germanys core business areas. From our headquarters in Amsterdam and Darmstadt and offices in Germany, Israel and the US we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germanys science and technology base.The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck KGaA, Darmstadt, Germanys business areas, though formally separated by a Chinese Wall. The total volume of the corporate venture fund is 400 million.We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.The Healthcare team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck KGaA, Darmstadt, Germany and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.The Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R

Corporate Venture Capital

Total Funds

Artificial Intelligence, Machine Learning
B2B, B2B2C, B2C
Hardware, Software


Christian Patze
Investment Director and Board Member
Robert Even
Business Development Manager
Noga Yerushalmi
Head of the Bioincubator

Investment Portfolio


Investment Round History

July 27, 2021
Series C
February 25, 2021
Series C
February 19, 2020
Series B


© 2022 StartupHub.ai. All rights reserved.

Register Pro to view more


$25 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export